Teva UK Ltd: UK Public Sector Contracts Won & Awards
Large organisation·Companies House: Private Limited Company·Castleford·Nationwide (UK)·Main market: Pharmaceutical products
Official UK PPONPWDD-6894-DXRMCompanies House00302461 ↗ · Active
Where they wini
i
229 awards (221 for a named lot, 97%, 8 for a whole procedure with no lot named) · top CPV classes, shares of all 229 awards. An award may cover more than one class.
3360 Pharmaceutical products224 awards · 98% · 216 awards naming a lot + 8 whole-procedure awards3369 Various medicinal products2 awards · 1% · awards naming a lot3314 Medical consumables1 award · <1% · awards naming a loti
i
Largest published awards i | Authority | Awarded | Term | Published value |
|---|---|---|---|---|
| Proprietary Drugs | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £9,890,507 † |
| Virus Testing Supplies | Department of Health & Social Care | — | — | £9,600,480 † |
| Proprietary Drugs | eTenderwales | — | — | £6,583,800 † |
| Generic Drugs - Tablets & Capsules | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £2,407,121 † |
| Aseptics Medicines (Including Cytotoxics) | NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | — | — | £1,646,000 † |
Where their buyers arei
i
ITL1 region of the buyer office · known for 125 of 125 awarded procedures · each procedure counts once
Bidding recordi
i
Procurement Act 2023 award notices name every bidder · 15 notices name this supplier, covering 21 lots since 20 Aug 2025 · observed bids, not an estimate
i
i
i
Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.
Who they sell toi
i
Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier
i
NHS & health93%(213 awards)
213 of 229 awards are NHS & health (93%).Type not classified7%(15 awards)
15 of 229 awards are Type not classified (7%).Central government0%(1 award)
1 of 229 awards is Central government (0%).
| Authority | Procedures | Share | Award records | Last activity |
|---|---|---|---|---|
| NHS England | 46 | 36.8% | 83 | 28 Oct 2026 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") | 42 | 33.6% | 88 | 27 Jul 2026 |
| NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) | 18 | 14.4% | 19 | 17 Sept 2026 |
| The NHS Commissioning Board (operating under the name of NHS England) | 10 | 8% | 28 | 7 Feb 2022 |
| Business Services Organisation Procurement and Logistics Service | 3 | 2.4% | 7 | 5 Jan 2026 |
| eTenderwales | 2 | 1.6% | 2 | 17 Jun 2025 |
| Public Health England | 2 | 1.6% | 2 | 23 Apr 2021 |
| Department of Health & Social Care | 1 | 0.8% | 1 | 28 Sept 2020 |
Share = of the 125 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.
Contracts endingi
i
187 of 231 awards carry an end date, 74 estimated from the duration · not a retender forecast
| Contract | Ends | Published value |
|---|---|---|
| Lot 4 - Progesterones | 30 Nov 2026 estimated | £1,438,484 ceiling |
| Lot 1 - CM/TNS/25/5725/01 | 31 Dec 2026 | £37,694,000 ceiling |
| Vincristine Without Preservatives Injection | 3 Jan 2027 estimated | £24,879 ceiling |
| Octreotide Powder And Solvent For Suspension For Injection Vials (unbundled - without homecare) | 3 Jan 2027 estimated | £29,694 ceiling |
| Dasatinib Tablets | 3 Jan 2027 estimated | £79,792 ceiling |
| Range of Generic Cancer Medicines (single supplier) | 3 Jan 2027 estimated | £3,432,063 ceiling |
| Octreotide Powder And Solvent For Suspension For Injection Vials (bundled - with homecare) | 3 Jan 2027 estimated | £17,607 ceiling |
| Generic Drugs - Tablets & Capsules | 31 Jan 2027 | £2,407,121 |
| Generic Anti-Infective Drugs | 31 Jan 2027 | £312,222 |
| Wave 15a - Hospital Only Products (DNW & DLN regions) | 31 Jan 2027 | £1 ceiling |
Soonest 10 of 45.
Recent awards
Latest 30 of 229 award records naming this supplier
Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.
About this data
- One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
- Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
- Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
- Contract end dates. Published on 113 of 231 awards, estimated from the published duration on 74 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
- Source. Official UK public procurement notices (Find a Tender and Contracts Finder), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses both feeds, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.